SUBSCRIBE
SUBSCRIBE

23andMe

NEWS
Business
23andMe Steals Another Genentech Vet for Roster
April 2, 2015
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
23andMe Dives Into Biotech With Ex-Genentech R&D Star at Helm
March 12, 2015
 · 
4 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
FDA
23andMe Wins FDA Approval for First Genetic Test Kit
February 20, 2015
 · 
2 min read
Biotech Bay
23andMe Study Uncovers The Genetics Of Motion Sickness
February 4, 2015
 · 
3 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Business
23andMe is Sharing Users’ Data Again, This Time With Pfizer
January 14, 2015
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Business
23andMe, Genentech Forge $60 Million Parkinson’s Research Deal
January 6, 2015
 · 
2 min read
Biotech Bay
23andMe, Inc., MyHeritage Partner To Combine DNA And Family Trees
October 22, 2014
 · 
1 min read
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Biotech Bay
FDA May Have Cracked Down, But 23andMe, Inc. Exec Remains Hopeful
September 17, 2014
 · 
1 min read
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Biotech Bay
23andMe, Inc. And FDA Find A Way To Work Together In Shifting Political Atmosphere
July 1, 2014
 · 
1 min read
Load More
AWARDS
  • 2022 Best Places to Work
JOBS
IN THE PRESS
Biotech Bay
23andMe Trials-in-Progress Poster Details Expansion Cohorts for 23ME-00610, an Investigational Antibody Targeting CD200R1, at The Society for Immunotherapy of Cancer’s (SITC) 2022 Annual Meeting
November 7, 2022
 · 
5 min read
Policy
23andMe Granted New FDA Clearance to Provide Interpretive Drug Information for a Commonly Prescribed Cholesterol Medication
October 27, 2022
 · 
5 min read
Business
23andMe to Report FY2023 Second Quarter Financial Results
October 24, 2022
 · 
3 min read
Biotech Bay
23andMe to Present at Upcoming Investor Conferences in November 2022
October 12, 2022
 · 
3 min read
Biotech Bay
23andMe Announces Trials-in-Progress Poster Presentation on 23ME-00610, An Investigational Antibody Targeting CD200R1, at The Society for Immunotherapy of Cancer’s (SITC) 2022 Annual Meeting
October 5, 2022
 · 
4 min read
Business
Daniel Chu Joins 23andMe as Chief Product Officer
September 19, 2022
 · 
3 min read
Biotech Beach
Illumina Genomics Forum to Feature 23andMe Co-founder and CEO Anne Wojcicki
August 22, 2022
 · 
3 min read
Business
23andMe Reports FY2023 First Quarter Financial Results
August 8, 2022
 · 
18 min read
Business
23andMe Reports FY2022 Fourth Quarter and Full Year Financial Results
May 26, 2022
 · 
23 min read
Business
23andMe to Report FY2022 Fourth Quarter and Full Year Financial Results
May 12, 2022
 · 
3 min read
Load More